SR | Intravenous immunoglobulin for the treatment of Kawasaki disease

Intravenous immunoglobulin for the treatment of Kawasaki disease – Cochrane Library

Summary: Immunoglobulin treatment for Kawasaki disease – Cochrane Library

Related:

Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression – Journal of the American Heart Association

Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan – JAMA Network Open

Systematic Review: Corticosteroids for the treatment of Kawasaki disease in children.

Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease

Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives – Frontiers in Medicine